Coreline Soft, a South Korea-based medical AI company specialising in thoracic imaging, announced on Saturday that it is collaborating with INFINITT North America, a developer of enterprise imaging solutions, to bridge the gap between advanced technology and daily clinical practice.
The partners have successfully deployed a fully automated, 'zero-click' AI reading solution now live in US radiology practices.
According to the companies, this deep-embed integration allows radiologists to access AI-powered insights directly within their familiar INFINITT PACS environment -- eliminating the need for extra clicks, new logins, or workflow interruptions.
By embedding Coreline's AVIEW AI platform directly into the INFINITT PACS, the integration automates coronary artery calcium (CAC) scoring, enhances lung nodule detection, and reduces case reading times.
To further support the US market, Coreline Soft has launched the INFINITT Integration Suite, a dedicated package for INFINITT users that enables rapid deployment of AI modules, supports CPT-based reimbursement, and delivers a hands-free experience for clinicians.
Cizzle Biotechnology secures Canadian patent for lung cancer biomarker test
DATROWAY receives US priority review for first-line metastatic triple negative breast cancer
Summit Therapeutics' BLA for ivonescimab in EGFR-mutated NSCLC accepted by FDA
Guerbet's contrast agent Elucirem approved by European Commission in children from birth
United Therapeutics reports positive phase 1 data for bioengineered liver in acute liver failure
European Commission approves GSK's Arexvy for adults aged 18 and over
Roivant to announce Q3 2026 financial results
Avacta secures FDA clearance for second pre|CISION oncology programme